Malignant Splenic Neoplasm — Trials

Malignant Splenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 35.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01804166	A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)	completed	Phase 4	1	Janssen Scientific Affairs, LLCINDUSTRY	1	Feb 4, 2025	clinicaltrials
NCT01746992	CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma	unknown	Phase 4	200	Ruijin HospitalOTHER	1	Nov 14, 2017